Illumina, Inc. (FRA:ILU)
81.14
-0.41 (-0.50%)
At close: Aug 8, 2025, 10:00 PM CET
Illumina Revenue
Illumina had revenue of $1.06B USD in the quarter ending June 29, 2025, a decrease of -4.77%. This brings the company's revenue in the last twelve months to $4.28B, down -3.27% year-over-year. In the year 2024, Illumina had annual revenue of $4.37B, down -2.93%.
Revenue (ttm)
$4.28B
Revenue Growth
-3.27%
P/S Ratio
3.63
Revenue / Employee
$474.42K
Employees
9,030
Market Cap
13.27B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 29, 2024 | 4.37B | -132.00M | -2.93% |
Dec 31, 2023 | 4.50B | -80.00M | -1.75% |
Jan 1, 2023 | 4.58B | 58.00M | 1.28% |
Jan 2, 2022 | 4.53B | 1.29B | 39.73% |
Jan 3, 2021 | 3.24B | -304.00M | -8.58% |
Dec 29, 2019 | Pro | Pro | Pro |
Dec 30, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Jan 1, 2017 | Pro | Pro | Pro |
Jan 3, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
SAP SE | 35.89B |
Siemens Aktiengesellschaft | 78.30B |
Deutsche Telekom AG | 120.55B |
Allianz SE | 123.69B |
Siemens Energy AG | 38.39B |
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 62.33B |
Rheinmetall AG | 10.67B |
Deutsche Bank Aktiengesellschaft | 30.07B |
Illumina News
- 9 days ago - What Does the Market Think About Illumina? - Benzinga
- 10 days ago - Illumina: The Stock Is Still Undervalued - Seeking Alpha
- 11 days ago - Illumina (ILMN) Q2 2025 Earnings Call Transcript - The Motley Fool
- 12 days ago - Illumina (ILMN) Q2 EPS Jumps 9% - The Motley Fool
- 12 days ago - These Analysts Boost Their Forecasts On Illumina Following Upbeat Results - Benzinga
- 12 days ago - These Analysts Boost Their Forecasts On Illumina Following Upbeat Results - Benzinga
- 13 days ago - Illumina raises 2025 revenue and EPS guidance as clinical demand strengthens and multiomics acquisition advances - Seeking Alpha
- 13 days ago - Illumina, Inc. 2025 Q2 - Results - Earnings Call Presentation - Seeking Alpha